Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Are active surveillance criteria sufficient for predicting advanced stage prostate cancer patients?

Celik, S.
Ongun, S.
Tuna, B.
Aslan, GÜVEN
Yorukoglu, K.
ÜNER, SARP
Gul-Niflioglu, G.
Mungan, U.

Publication date

October 2014

DOI

10.1016/j.acuro.2013.11.005

Publisher

Elsevier BV

Abstract

Objectives: To examine the treatment outcomes of the prostate cancer (PCa) patients treated by radical prostatectomy (RP) who could be good candidates for active surveillance (AS) and test the confidence and reliability of the AS criterias for predicting advanced stage disease (RP Gleason score >= 7 or Pathological stage T3)

Extracted data

Related items

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.

Gandaglia, G.
van den Bergh, RCN
Tilki, D.
Fossati, N.
Ost, P.
Surcel, C.I.
Sooriakumaran, P.
Tsaur, I.
Valerio, M.
Kretschmer, A.
Zaffuto, E.
Salomon, L.
Montorsi, F.
Graefen, M.
van der Poel, H.
de la Taille, A.
Briganti, A.
Ploussard, G.

November 2018

To develop a novel tool to increase the number of patients with prostate cancer eligible for active ...

Active surveillance for prostate cancer: a systematic review of the literature.

Dall'Era, Marc A
Albertsen, Peter C
Bangma, Christopher
Carroll, Peter R
Carter, H Ballentine
Cooperberg, Matthew R
Freedland, Stephen J
Klotz, Laurence H
Parker, Christopher
Soloway, Mark S

December 2012

ContextProstate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal manage...

Active surveillance for prostate cancer: when to recommend delayed intervention.

Babaian, Kara N

November 2015

There are no agreed upon guidelines for placing patients on active surveillance (AS). Therefore, the...

Are active surveillance criteria sufficient for predicting advanced stage prostate cancer patients?

ÜNER, SARP
Gul-Niflioglu, G.
Celik, S.
Ongun, S.
Tuna, B.
Aslan, GÜVEN
Mungan, U.
Yorukoglu, K.

October 2014

Objectives: To examine the treatment outcomes of the prostate cancer (PCa) patients treated by radic...

Pathological Outcome in Men with Prostate Cancer Suitable for Active Surveillance after Radical Prostatectomy

Grace Tan MBBS, MRSC
Henry Ho MBBS, FAMS (Urology)
Hong g Huang MBBS, CTR
Christopher Wai Sam Cheng MBBS, FAMS (Urology)
Weber Kam On Lau MBBS, FAMS (Urology)

June 2012

Background: Active surveillance (AS) as a treatment option for low risk prostate cancer is gaining r...

Current status of active surveillance in prostate cancer.

이승환

February 2017

Active surveillance (AS) is a management strategy involving close monitoring the course of disease w...

Identification of Pathologically Favorable Disease in Intermediate-Risk Prostate Cancer Patients: Implications for Active Surveillance Candidates Selection

Gandaglia G
Schiffmann J
Schlomm T
Fossati N
Moschini M
Suardi N
Chun FKH
Montorsi F
Graefen M
Briganti A

January 2015

BACKGROUND. Intermediate-risk prostate cancer (PCa) represents a heterogeneous disease, where a non-...

Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer

Suardi N
Briganti A
Gallina A
Salonia A
Karakiewicz PI
Capitanio U
Freschi M
Cestari A
Guazzoni G
Rigatti P
Montorsi F

January 2010

OBJECTIVE To test the ability of two of the most stringent criteria used to identify patients with l...

Multicenter analysis of pathological outcomes of patients eligible for active surveillance according to PRIAS criteria

Grasso, A. A.
Cozzi, G.
De Lorenzis, E.
Ceruti, C.
Crivellaro, S.
Falsaperla, M.
Minervini, A.
Masieri, L.
Serni, S.
Porreca, A.
Zaramella, S.
Rocco, Bernardo Maria Cesare

January 2016

AIM: To retrospectively analyze the pathological outcomes of patients meeting the Prostate Cancer Re...

Currently Used Criteria for Active Surveillance in Men With Low-risk Prostate Cancer An Analysis of Pathologic Features

Suardi N
Capitanio U
Chun FKH
Graefen M
Perrotte P
Schlomm T
Haese A
Huland H
Erbersdobler A
Montorsi F
Karakiewicz PI

January 2008

BACKGROUND. Active surveillance (AS) represents a treatment option for select patients with low-risk...

Multicenter analysis of pathological outcomes of patients eligible for active surveillance according to prias criteria

A.A. Grasso
G. Cozzi
E. De Lorenzis
C. Ceruti
S. Crivellaro
M. Falsaperla
A. Minervini
L. Masieri
S. Serni
A. Porreca
S. Zaramella
B. Rocco

June 2016

AIM: To retrospectively analyze the pathological outcomes of patients meeting the Prostate Cancer Re...

Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer

Jung Ki Jo
Han Sol Lee
Young Ik Lee
Sang Eun Lee
Sung Kyu Hong

April 2015

We aimed to analyze the value of each criterion for clinically insignificant prostate cancer (PCa) i...

Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

Dall'Era, MA
Albertsen, PC
Bangma, C.H.
Carroll, PR
Carter, HB
Cooperberg, MR
Freedland, SJ
Klotz, LH
Parker, C
Soloway, MS

January 2012

Context: Prostate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal mana...

Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer.

Gnanapragasam, Vincent
Barrett, Tristan
Thankapannair, Vineetha
Thurtle, David
Rubio-Briones, Jose
Domínguez-Escrig, Jose
Bratt, Ola
Statin, Par
Muir, Kenneth
Lophatananon, Artitaya

November 2019

OBJECTIVES: To test whether using disease prognosis can inform a rational approach to active surveil...

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients

Ploussard, G.
Isbarn, H.
Briganti, A.
Sooriakumaran, P.
Surcel, C.I.
Salomon, L.
Freschi, M.
Mirvald, C.
Poel, H.G. van der
Jenkins, A.
Ost, P.
Oort, I.M. van
Yossepowitch, O.
Giannarini, G.
Bergh, R.C. van den

January 2015

Item does not contain fulltextOBJECTIVE: To test the expandability of active surveillance (AS) to Gl...

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.

Gandaglia, G.
van den Bergh, RCN
Tilki, D.
Fossati, N.
Ost, P.
Surcel, C.I.
Sooriakumaran, P.
Tsaur, I.
Valerio, M.
Kretschmer, A.
Zaffuto, E.
Salomon, L.
Montorsi, F.
Graefen, M.
van der Poel, H.
de la Taille, A.
Briganti, A.
Ploussard, G.

November 2018

To develop a novel tool to increase the number of patients with prostate cancer eligible for active ...

Active surveillance for prostate cancer: a systematic review of the literature.

Dall'Era, Marc A
Albertsen, Peter C
Bangma, Christopher
Carroll, Peter R
Carter, H Ballentine
Cooperberg, Matthew R
Freedland, Stephen J
Klotz, Laurence H
Parker, Christopher
Soloway, Mark S

December 2012

ContextProstate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal manage...

Active surveillance for prostate cancer: when to recommend delayed intervention.

Babaian, Kara N

November 2015

There are no agreed upon guidelines for placing patients on active surveillance (AS). Therefore, the...

Are active surveillance criteria sufficient for predicting advanced stage prostate cancer patients?

ÜNER, SARP
Gul-Niflioglu, G.
Celik, S.
Ongun, S.
Tuna, B.
Aslan, GÜVEN
Mungan, U.
Yorukoglu, K.

October 2014

Objectives: To examine the treatment outcomes of the prostate cancer (PCa) patients treated by radic...

Pathological Outcome in Men with Prostate Cancer Suitable for Active Surveillance after Radical Prostatectomy

Grace Tan MBBS, MRSC
Henry Ho MBBS, FAMS (Urology)
Hong g Huang MBBS, CTR
Christopher Wai Sam Cheng MBBS, FAMS (Urology)
Weber Kam On Lau MBBS, FAMS (Urology)

June 2012

Background: Active surveillance (AS) as a treatment option for low risk prostate cancer is gaining r...

Current status of active surveillance in prostate cancer.

이승환

February 2017

Active surveillance (AS) is a management strategy involving close monitoring the course of disease w...

Identification of Pathologically Favorable Disease in Intermediate-Risk Prostate Cancer Patients: Implications for Active Surveillance Candidates Selection

Gandaglia G
Schiffmann J
Schlomm T
Fossati N
Moschini M
Suardi N
Chun FKH
Montorsi F
Graefen M
Briganti A

January 2015

BACKGROUND. Intermediate-risk prostate cancer (PCa) represents a heterogeneous disease, where a non-...

Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer

Suardi N
Briganti A
Gallina A
Salonia A
Karakiewicz PI
Capitanio U
Freschi M
Cestari A
Guazzoni G
Rigatti P
Montorsi F

January 2010

OBJECTIVE To test the ability of two of the most stringent criteria used to identify patients with l...

Multicenter analysis of pathological outcomes of patients eligible for active surveillance according to PRIAS criteria

Grasso, A. A.
Cozzi, G.
De Lorenzis, E.
Ceruti, C.
Crivellaro, S.
Falsaperla, M.
Minervini, A.
Masieri, L.
Serni, S.
Porreca, A.
Zaramella, S.
Rocco, Bernardo Maria Cesare

January 2016

AIM: To retrospectively analyze the pathological outcomes of patients meeting the Prostate Cancer Re...

Currently Used Criteria for Active Surveillance in Men With Low-risk Prostate Cancer An Analysis of Pathologic Features

Suardi N
Capitanio U
Chun FKH
Graefen M
Perrotte P
Schlomm T
Haese A
Huland H
Erbersdobler A
Montorsi F
Karakiewicz PI

January 2008

BACKGROUND. Active surveillance (AS) represents a treatment option for select patients with low-risk...

Multicenter analysis of pathological outcomes of patients eligible for active surveillance according to prias criteria

A.A. Grasso
G. Cozzi
E. De Lorenzis
C. Ceruti
S. Crivellaro
M. Falsaperla
A. Minervini
L. Masieri
S. Serni
A. Porreca
S. Zaramella
B. Rocco

June 2016

AIM: To retrospectively analyze the pathological outcomes of patients meeting the Prostate Cancer Re...

Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer

Jung Ki Jo
Han Sol Lee
Young Ik Lee
Sang Eun Lee
Sung Kyu Hong

April 2015

We aimed to analyze the value of each criterion for clinically insignificant prostate cancer (PCa) i...

Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

Dall'Era, MA
Albertsen, PC
Bangma, C.H.
Carroll, PR
Carter, HB
Cooperberg, MR
Freedland, SJ
Klotz, LH
Parker, C
Soloway, MS

January 2012

Context: Prostate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal mana...

Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer.

Gnanapragasam, Vincent
Barrett, Tristan
Thankapannair, Vineetha
Thurtle, David
Rubio-Briones, Jose
Domínguez-Escrig, Jose
Bratt, Ola
Statin, Par
Muir, Kenneth
Lophatananon, Artitaya

November 2019

OBJECTIVES: To test whether using disease prognosis can inform a rational approach to active surveil...

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients

Ploussard, G.
Isbarn, H.
Briganti, A.
Sooriakumaran, P.
Surcel, C.I.
Salomon, L.
Freschi, M.
Mirvald, C.
Poel, H.G. van der
Jenkins, A.
Ost, P.
Oort, I.M. van
Yossepowitch, O.
Giannarini, G.
Bergh, R.C. van den

January 2015

Item does not contain fulltextOBJECTIVE: To test the expandability of active surveillance (AS) to Gl...

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.

Gandaglia, G.
van den Bergh, RCN
Tilki, D.
Fossati, N.
Ost, P.
Surcel, C.I.
Sooriakumaran, P.
Tsaur, I.
Valerio, M.
Kretschmer, A.
Zaffuto, E.
Salomon, L.
Montorsi, F.
Graefen, M.
van der Poel, H.
de la Taille, A.
Briganti, A.
Ploussard, G.

November 2018

To develop a novel tool to increase the number of patients with prostate cancer eligible for active ...

Active surveillance for prostate cancer: a systematic review of the literature.

Dall'Era, Marc A
Albertsen, Peter C
Bangma, Christopher
Carroll, Peter R
Carter, H Ballentine
Cooperberg, Matthew R
Freedland, Stephen J
Klotz, Laurence H
Parker, Christopher
Soloway, Mark S

December 2012

ContextProstate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal manage...

Active surveillance for prostate cancer: when to recommend delayed intervention.

Babaian, Kara N

November 2015

There are no agreed upon guidelines for placing patients on active surveillance (AS). Therefore, the...